Imagen de Portada

Commentary on “Pedal Medial Arterial Calcification in Diabetic Foot Ulcers: A Significant Risk Factor of Amputation and Mortality”

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Mostafa Javanian, Mohammad Barary, Ali Alizadeh Khatir, Majid Khalilizad, Soheil Ebrahimpour
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Journal of Diabetes
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Commentary on “Analysis of Factors Influencing the Recurrence of Diabetic Foot Ulcers”
por: Mostafa Javanian, et al.
Publicado: (2024)

Commentary on “Effects of Diabetes‐Related Foot Ulcer Depth on Healing Days, Cost, and Quality of Life: A Prospective Observational Study”
por: Mostafa Javanian, et al.
Publicado: (2024)

Commentary on “Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”
por: Mostafa Javanian, et al.
Publicado: (2024)

Commentary on “Differences in Characteristics Between First‐Ever Foot Ulcer and Recurrent Foot Ulcer in Patients With Diabetes: Prospective Observational Study”
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Polymicrobial Infection in Bone Biopsies and Relapse in Diabetic Foot Osteomyelitis: The Role of Soft Tissue Involvement”
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study”
por: Fatemeh Rasulpur, et al.
Publicado: (2025)

Comments on Successful Treatment of a High‐Risk Diabetic Foot Ulcer by Ozone Therapy and Collagen Powder: A Case Report
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Protective Effect of Regular Physical Activity Against Diabetes‐Related Lower Extremity Amputation”
por: Zeinab Mohseni Afshar, et al.
Publicado: (2025)

Commentary on “The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type”
por: Majid Khalilizad, et al.
Publicado: (2025)

Commentary on “Explore the Effect of Low‐Intensity Focused Ultrasound on Pain Relief in Patients With Diabetic Peripheral Neuropathy”
por: Danial Hosseinzadeh, et al.
Publicado: (2025)

Comments on “Comparative Study on the Efficacy of PRP Gel and UC‐MSCs Gel as Adjuvant Therapies in the Treatment of DFU Wounds”
por: Mostafa Javanian, et al.
Publicado: (2024)

Comments on ‘The impact of inflammatory biomarkers on amputation rates in patients with diabetic foot ulcers’
por: Mostafa Javanian, et al.
Publicado: (2024)

Commentary on “Racial disparities in patients with amputation in an acute care setting in the immediate postoperative period”
por: Majid Khalilizad, et al.
Publicado: (2025)

Commentary on “The infected diabetic foot: Incidence and risk factors for dehiscence after surgery for diabetic foot infections”
por: Majid Khalilizad, et al.
Publicado: (2025)

Commentary on “Evaluation of Neuropathic Pain in Lower Extremity Wounds Using Different Assessment Tools: A Cross‐Sectional Study”
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
por: Pouya Tayebi, et al.
Publicado: (2025)

Commentary on “The Association of Circulating Bone Morphogenetic Protein 9 and Arterial Stiffness in Hypertensive Patients”
por: Naghmeh Ziaie, et al.
Publicado: (2025)

Commentary on “Association of neutrophil–lymphocyte ratio, platelet–lymphocyte ratio and monocyte‐to‐high‐density lipoprotein ratio with diabetic nephropathy”
por: Mostafa Javanian, et al.
Publicado: (2025)

Association of Incident Diabetic Foot Ulcer With Lower‐Extremity Amputation Risk: The Prospective Seattle Diabetic Foot Study
por: Ibrahim S. Al‐Busaidi, et al.
Publicado: (2025)

Commentary on “Association of Plasma Homocysteine With Peripheral Arterial Disease in Hypertensive Adults: A Cross‐Sectional Study”
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus”
por: Fatemeh Rasulpur, et al.
Publicado: (2025)

Antimicrobial resistance is not increasing in subsequent cases of ischaemic foot infections, a single‐centre cohort from 2012 to 2021
por: Mostafa Javanian, et al.
Publicado: (2024)

Commentary on “Hepatitis C virus infection increases risk of peripheral arterial disease in end‐stage renal disease patients receiving maintenance hemodialysis therapy”
por: Mostafa Javanian, et al.
Publicado: (2025)

Age Characteristics of Patients With Type 2 Diabetic Foot Ulcers and Predictive Risk Factors for Lower Limb Amputation: A Population‐Based Retrospective Study
por: Yuanying Yao, et al.
Publicado: (2024)

Commentary on ‘The Nonlinear Association Between Catheterisation Duration and Urinary Tract Infection in Patients With Geriatric Hip Fracture: A Retrospective Study’
por: Mohammad Barary, et al.
Publicado: (2025)

Commentary on “Ferritin to Albumin Ratio Predicts Mortality in Peritoneal Dialysis Patients”
por: Mohammad Barary, et al.
Publicado: (2025)

Commentary on “Patient Race and Ethnicity Do Not Predict Ulceration Among Ambulatory Patients With Venous Insufficiency”
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Vitabiotic: An Alternative Approach to Diabetic Foot”
por: Zeinab Mohseni Afshar, et al.
Publicado: (2025)

Commentary on “Treating cellulitis promptly with compression therapy reduces C‐reactive protein levels and symptoms – a randomized‐controlled trial”
por: Mostafa Javanian, et al.
Publicado: (2025)

Comments on “The treatment effect of endovascular therapy for chronic limb‐threatening ischemia with systemic sclerosis”
por: Mostafa Javanian, et al.
Publicado: (2025)

Commentary on “Efficacy and Safety of Once‐Daily Prolonged‐Release Pregabalin for the Treatment of Patients With Diabetic Peripheral Neuropathy: A Randomized, Double‐Blind, Active, and Placebo‐Controlled Trial”
por: Mohammad Barary, et al.
Publicado: (2025)

Comprehensive Management of Diabetic Foot Ulcers: Current Evidence and Practice
por: Ji Min Kim, et al.
Publicado: (2026)

Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
por: Majid Khalilizad, et al.
Publicado: (2025)

Procalcitonin and Diabetic Foot Ulcer Infections: A Meta‐Analysis
por: Wenqiang Wang, et al.
Publicado: (2025)

The Role of Negative Pressure Therapy in Diabetic Foot Ulcer: A Meta‐Analysis
por: Hai Du, et al.
Publicado: (2026)

Advancing Diabetic Foot Ulcer Care: Focus on the Post‐Healing Transition Phase
por: Kamran Shakir, et al.
Publicado: (2025)

Insights Into Macrophage Polarization and M1 / M2 Balance in Diabetic Foot Ulcers
por: Jing Zhang, et al.
Publicado: (2026)

Correlation Analysis of Lower Limb Venous Dilation in Patients With Diabetic Foot Ulcers
por: Rumei Li, et al.
Publicado: (2025)

Commentary on “HDL‐C/LDL‐C Ratio and All‐Cause Mortality in Populations at High CVD Risk: A Prospective Observational Cohort Study”
por: Naghmeh Ziaie, et al.
Publicado: (2025)

Predicting Diabetic Foot Ulcer Outcomes: Machine Learning‐Based Refinement of IWGDF ‐Approved Classifications for Outpatient Services
por: Farideh Mostafavi, et al.
Publicado: (2026)